Breast cancer is very heterogeneous in terms of histological types and clinical outcomes, namely having different patterns of positivity for estrogen and progesterone receptors, as well as for the expression of the oncogene human epidermal growth factor receptor 2 (HER-2). The gene discussed is ERBB2; the disease is breast carcinoma.